What is an MDR Gap Analysis?
Until
today, medical devices were complying with the Medical Device Directive to sell
their products in Europe. However major amendments are made in the current MDD
to keep up with the growing technological advances in healthcare and medical
devices. The new regulations passed by the Council of the European Union is
Medical Device Regulations (MDR) 2017/745 that came into force in May 2017
& manufacturers have a transition time of three years until May 2021 to
comply with the new regulations.
An MDR Gap Analysis is the process of systematically examining a medical device’s clinical
evidence portfolio to determine whether it demonstrates conformity with all
relevant MDR requirements. It is a crucial first step in developing and
maintaining an MDR compliance strategy.
Typically,
all MDD-MDR transition projects initiate with Gap Assessment. Gap Assessment is
a crucial activity during MDR transition & our team with engineering &
regulatory expertise are well equipped to conduct this activity with an
analytical mindset, resolve any regulatory concern and develop robust
regulatory strategy for medical device manufacturers.
IZiel’s
“ONE-STOP COMPLETE SOLUTION” include –
- ·
Gap
Assessment
- ·
Technical
File Preparation
- ·
QMS
Documentation
- ·
Expert
Review & Recommendations
- ·
European
Authorized Representative (EC REP)
- ·
EUDAMED
- ·
Mock
Audits & Trainings
- ·
PRRC
Services
- ·
Clinical
Evaluation Plan & Report
- ·
Software
Validation
IZiel team
of specialists and quality professionals look forward to support more medical
device companies to file their devices under the MDR 2017/745.
Comments
Post a Comment